Story perspectives

Study Reveals Lower Genetic Cystine Stone Prevalence Than Expected

4/10/2026

Summary

Story summary

The study finds genetic prevalence of cystine stone predisposition is 1 in 17,612, below the clinical prevalence of 1 in 7,000.
Discrepancies may reflect undiscovered genes and consanguinity in populations such as Saudi Arabia.
Current population databases rely on short-read sequencing, potentially missing larger structural variants.
Even with more pathogenic variants in SLC3A1 and SLC7A9, genetic prevalence stays lower than clinical estimates, indicating a need for better sequencing.

1 of 1

Story summary

The study finds genetic prevalence of cystine stone predisposition is 1 in 17,612, below the clinical prevalence of 1 in 7,000.
Discrepancies may reflect undiscovered genes and consanguinity in populations such as Saudi Arabia.
Current population databases rely on short-read sequencing, potentially missing larger structural variants.
Even with more pathogenic variants in SLC3A1 and SLC7A9, genetic prevalence stays lower than clinical estimates, indicating a need for better sequencing.